• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    10 Biggest Price Target Changes For Thursday

    12/9/21 10:28:21 AM ET
    $CINF
    $DOW
    $DRNA
    $ESPR
    Property-Casualty Insurers
    Finance
    Major Chemicals
    Industrials
    Get the next $CINF alert in real time by email
    • SVB Leerink boosted the price target on Edwards Lifesciences Corporation (NYSE:EW) from $130 to $135. Edwards Lifesciences shares rose 1% to trade at $120.68 on Thursday.
    • Keybanc raised The Sherwin-Williams Company (NYSE:SHW) price target from $350 to $384. Sherwin-Williams shares rose 1% to $345.68 on Thursday.
    • Piper Sandler cut Udemy, Inc. (NASDAQ:UDMY) price target from $37 to $34. Udemy shares fell 2% to trade at $20.65 on Thursday.
    • Needham lowered the price target on Esperion Therapeutics, Inc. (NASDAQ:ESPR) from $20 to $12. Esperion Therapeutics shares dropped 9% to $5.34 on Thursday.
    • JP Morgan lifted Phillips 66 (NYSE:PSX) price target from $83 to $93. Phillips 66 shares rose 0.7% to $72.36 on Thursday.
    • RBC Capital cut the price target for Cincinnati Financial Corporation (NASDAQ:CINF) from $135 to $130. Cincinnati Financial shares fell 1.7% to $115.23 on Thursday.
    • Chardan Capital raised Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) price target from $28 to $38.25. Dicerna Pharmaceuticals shares rose 0.1% to $38.03 on Thursday.
    • Morgan Stanley boosted the price target on Oshkosh Corporation (NYSE:OSK) from $134 to $144. Oshkosh shares fell 1.4% to trade at $111.45 on Thursday.
    • Wells Fargo cut the price target for Dow Inc. (NYSE:DOW) from $75 to $67. Dow shares fell 0.8% to $54.49 on Thursday.
    • Barclays raised McKesson Corporation (NYSE:MCK) price target from $270 to $290. McKesson shares rose 1.1% to $229.33 on Thursday.

    Check out other big price target changes here

    Get the next $CINF alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CINF
    $DOW
    $DRNA
    $ESPR

    CompanyDatePrice TargetRatingAnalyst
    Oshkosh Corporation (Holding Company)
    $OSK
    2/3/2026$149.00Underperform → Neutral
    BofA Securities
    Sherwin-Williams Company
    $SHW
    1/23/2026$380.00Buy → Hold
    Deutsche Bank
    Udemy Inc.
    $UDMY
    1/13/2026Overweight → Sector Weight
    KeyBanc Capital Markets
    Edwards Lifesciences Corporation
    $EW
    1/9/2026$97.00Hold → Buy
    TD Cowen
    Sherwin-Williams Company
    $SHW
    1/7/2026$371.00Hold → Buy
    Vertical Research
    Sherwin-Williams Company
    $SHW
    12/18/2025$390.00Neutral → Buy
    Citigroup
    Edwards Lifesciences Corporation
    $EW
    12/18/2025$100.00Neutral → Overweight
    Analyst
    McKesson Corporation
    $MCK
    12/9/2025$960.00Overweight
    Barclays
    More analyst ratings

    $CINF
    $DOW
    $DRNA
    $ESPR
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for NEXLIZET issued to ESPERION THERAPS INC

    Submission status for ESPERION THERAPS INC's drug NEXLIZET (SUPPL-16) with active ingredient BEMPEDOIC ACID; EZETIMIBE has changed to 'Approval' on 03/22/2024. Application Category: NDA, Application Number: 211617, Application Classification: Efficacy

    3/25/24 4:41:30 AM ET
    $ESPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for NEXLIZET issued to ESPERION THERAPS INC

    Submission status for ESPERION THERAPS INC's drug NEXLIZET (SUPPL-17) with active ingredient BEMPEDOIC ACID; EZETIMIBE has changed to 'Approval' on 03/22/2024. Application Category: NDA, Application Number: 211617, Application Classification: Efficacy

    3/25/24 4:41:37 AM ET
    $ESPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for NEXLETOL issued to ESPERION THERAPS INC

    Submission status for ESPERION THERAPS INC's drug NEXLETOL (SUPPL-13) with active ingredient BEMPEDOIC ACID has changed to 'Approval' on 03/22/2024. Application Category: NDA, Application Number: 211616, Application Classification: Efficacy

    3/25/24 4:41:29 AM ET
    $ESPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CINF
    $DOW
    $DRNA
    $ESPR
    SEC Filings

    View All

    Udemy Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Udemy, Inc. (0001607939) (Filer)

    2/5/26 4:07:08 PM ET
    $UDMY
    Other Consumer Services
    Real Estate

    SEC Form 10-Q filed by McKesson Corporation

    10-Q - MCKESSON CORP (0000927653) (Filer)

    2/4/26 5:30:50 PM ET
    $MCK
    Other Pharmaceuticals
    Health Care

    McKesson Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - MCKESSON CORP (0000927653) (Filer)

    2/4/26 4:05:57 PM ET
    $MCK
    Other Pharmaceuticals
    Health Care

    $CINF
    $DOW
    $DRNA
    $ESPR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Oshkosh upgraded by BofA Securities with a new price target

    BofA Securities upgraded Oshkosh from Underperform to Neutral and set a new price target of $149.00

    2/3/26 6:50:34 AM ET
    $OSK
    Auto Manufacturing
    Industrials

    Sherwin-Williams downgraded by Deutsche Bank with a new price target

    Deutsche Bank downgraded Sherwin-Williams from Buy to Hold and set a new price target of $380.00

    1/23/26 8:14:28 AM ET
    $SHW
    RETAIL: Building Materials
    Consumer Discretionary

    Udemy downgraded by KeyBanc Capital Markets

    KeyBanc Capital Markets downgraded Udemy from Overweight to Sector Weight

    1/13/26 9:07:49 AM ET
    $UDMY
    Other Consumer Services
    Real Estate

    $CINF
    $DOW
    $DRNA
    $ESPR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Coursera Reports Fourth Quarter and Full Year 2025 Financial Results

    Delivered fourth quarter revenue of $197 million, up 10% year over year, driven by Consumer segment revenue growth of 12% year over year Achieved full year 2025 revenue of $757 million, up 9% from the prior year Generated full year 2025 net cash provided by operating activities of $109 million and Free Cash Flow of $78 million Provides full year 2026 revenue guidance in the range of $805 to $815 million Coursera, Inc. (NYSE:COUR), a leading global online learning platform, today announced financial results for its fourth quarter and full year ended December 31, 2025. A shareholder letter containing additional discussion of the Company's performance and outlook has been posted t

    2/5/26 4:10:00 PM ET
    $COUR
    $UDMY
    Computer Software: Prepackaged Software
    Technology
    Other Consumer Services
    Real Estate

    Udemy Reports Fourth Quarter and Full Year 2025 Results

    Full year 2025 consolidated subscription revenue increased 8% year-over-year Added $13 million in Net New Annual Recurring Revenue in Q4 Net Dollar Retention Rate stabilized at 97% for Large Customers and 93% total Expanded full year 2025 Adjusted EBITDA Margin by 700 basis points Udemy (NASDAQ:UDMY), a leading AI-powered skills acceleration platform, today reported results for the three- and twelve-month periods ended December 31, 2025. In light of the pending combination with Coursera (NYSE:COUR), which remains subject to shareholder and regulatory approvals and other customary closing conditions, Udemy will not host a conference call to discuss the results and will not provide

    2/5/26 4:05:00 PM ET
    $COUR
    $UDMY
    Computer Software: Prepackaged Software
    Technology
    Other Consumer Services
    Real Estate

    U.S. Army Continues Investment in Oshkosh FMTV A2 LVADs with Additional $25 Million Order

    Oshkosh Defense, an Oshkosh Corporation (NYSE:OSK) company, announced today it was awarded an additional $25 million contract from the U.S. Army to deliver FMTV A2 Low-Velocity Airdrop (LVAD) 4x4 Cargo vehicles and kits. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260205936929/en/Oshkosh Defense FMTV A2 LVAD 4x4 and 6x6. This order, following a recent Army contract for 97 vehicles, demonstrates strong and sustained customer demand for mission-critical tactical mobility solutions in extreme environments. "This award underscores our commitment to supporting the U.S. Army with proven, mission-ready capabilities that perform wh

    2/5/26 8:45:00 AM ET
    $OSK
    Auto Manufacturing
    Industrials

    $CINF
    $DOW
    $DRNA
    $ESPR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, GC and Secretary Sutherland Vanessa Allen sold $659,100 worth of shares (4,394 units at $150.00), decreasing direct ownership by 15% to 25,799 units (SEC Form 4)

    4 - Phillips 66 (0001534701) (Issuer)

    2/5/26 5:11:18 PM ET
    $PSX
    Integrated oil Companies
    Energy

    Pres. & GM, Glob. Supply Chain Davie Colin M. sold $1,069,872 worth of shares (2,976 units at $359.50) and exercised 2,976 shares at a strike of $127.98 (SEC Form 4)

    4 - SHERWIN WILLIAMS CO (0000089800) (Issuer)

    2/4/26 5:54:17 PM ET
    $SHW
    RETAIL: Building Materials
    Consumer Discretionary

    Director Wu Cheng-Sheng Peter was granted 847 shares (SEC Form 4)

    4 - CINCINNATI FINANCIAL CORP (0000020286) (Issuer)

    2/2/26 3:49:59 PM ET
    $CINF
    Property-Casualty Insurers
    Finance

    $CINF
    $DOW
    $DRNA
    $ESPR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Wilkins Edward Scott bought $22,928 worth of shares (140 units at $163.77) (SEC Form 4)

    4 - CINCINNATI FINANCIAL CORP (0000020286) (Issuer)

    12/5/25 3:32:18 PM ET
    $CINF
    Property-Casualty Insurers
    Finance

    Director Debbink Dirk J bought $153,980 worth of shares (1,000 units at $153.98) (SEC Form 4)

    4 - CINCINNATI FINANCIAL CORP (0000020286) (Issuer)

    10/30/25 3:45:04 PM ET
    $CINF
    Property-Casualty Insurers
    Finance

    Director Hayes Gregory bought $1,001,165 worth of shares (8,350 units at $119.90), increasing direct ownership by 40% to 29,423 units (SEC Form 4)

    4 - Phillips 66 (0001534701) (Issuer)

    8/14/25 5:27:46 PM ET
    $PSX
    Integrated oil Companies
    Energy

    $CINF
    $DOW
    $DRNA
    $ESPR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Udemy Inc.

    SC 13G/A - Udemy, Inc. (0001607939) (Subject)

    11/14/24 4:14:17 PM ET
    $UDMY
    Other Consumer Services
    Real Estate

    Amendment: SEC Form SC 13G/A filed by Esperion Therapeutics Inc.

    SC 13G/A - Esperion Therapeutics, Inc. (0001434868) (Subject)

    11/14/24 8:42:21 AM ET
    $ESPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Oshkosh Corporation (Holding Company)

    SC 13G/A - OSHKOSH CORP (0000775158) (Subject)

    11/12/24 4:56:28 PM ET
    $OSK
    Auto Manufacturing
    Industrials

    $CINF
    $DOW
    $DRNA
    $ESPR
    Leadership Updates

    Live Leadership Updates

    View All

    Valtris Specialty Chemicals Announces New Chief Executive Officer

    Industry veteran Mike McGaugh appointed Valtris Specialty Chemicals ("Valtris"), a leading global manufacturer of a comprehensive portfolio of specialty additives, announced today the appointment of Mike McGaugh as the company's new Chief Executive Officer. Mr. McGaugh has assumed the role held by former CEO, Simon Medley, who will be retiring as part of this transition but will continue to advise the company. Valtris is a portfolio company of SK Capital. "We are thrilled to welcome Mike, an industry veteran with a proven track record in the chemical and materials industries," said Jack Norris, a Managing Director of SK Capital. "Mike's decades of demonstrated leadership experience and

    1/13/26 6:30:00 AM ET
    $DOW
    $MYE
    Major Chemicals
    Industrials
    Plastic Products

    JFrog Appoints Genefa Murphy as Chief Marketing Officer to Accelerate Its Next Growth Phase

    Company Extends Executive Leadership to Lead the AI-Driven Software Supply Chain Evolution JFrog Ltd. (NASDAQ:FROG), the Liquid Software company, today announced the appointment of Genefa Murphy as Chief Marketing Officer, effective immediately. Murphy brings an expansive resume to JFrog, as a seasoned CMO and go-to-market (GTM) leader with established success in driving global enterprise software growth and strategic business expansion. Coming from software development product management roots and public company GTM leadership, Ms. Murphy also holds a PhD in User Acceptance of New Technology, from the University of Wales and is a veteran of multiple boards of directors in technology and

    1/5/26 8:00:00 AM ET
    $FIVN
    $FROG
    $HPE
    EDP Services
    Technology
    Computer Software: Prepackaged Software
    Retail: Computer Software & Peripheral Equipment

    Cyclum NextGen Travel Centers Continues with Phillips 66 for Historic Snowball Derby

    Cyclum NextGen Travel Centers is proud to return to the historic Snowball Derby at Five Flags Speedway with its driver Kole Raz for the most iconic Super Late Model race in the country. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206803293/en/Kole Raz practicing December 4, 2025 for the 2025 Snowball Derby at Five Flags Speedway in Pensacola, FL. The team will showcase its branding agreement with Phillips 66 through the iconic 76® brand, featuring the 76® Renewable Diesel-branded car. Driver Kole Raz will proudly represent both brands as he takes on one of the most competitive stages in short-track racing, further strength

    12/5/25 6:02:00 PM ET
    $PSX
    Integrated oil Companies
    Energy

    $CINF
    $DOW
    $DRNA
    $ESPR
    Financials

    Live finance-specific insights

    View All

    Coursera Reports Fourth Quarter and Full Year 2025 Financial Results

    Delivered fourth quarter revenue of $197 million, up 10% year over year, driven by Consumer segment revenue growth of 12% year over year Achieved full year 2025 revenue of $757 million, up 9% from the prior year Generated full year 2025 net cash provided by operating activities of $109 million and Free Cash Flow of $78 million Provides full year 2026 revenue guidance in the range of $805 to $815 million Coursera, Inc. (NYSE:COUR), a leading global online learning platform, today announced financial results for its fourth quarter and full year ended December 31, 2025. A shareholder letter containing additional discussion of the Company's performance and outlook has been posted t

    2/5/26 4:10:00 PM ET
    $COUR
    $UDMY
    Computer Software: Prepackaged Software
    Technology
    Other Consumer Services
    Real Estate

    Udemy Reports Fourth Quarter and Full Year 2025 Results

    Full year 2025 consolidated subscription revenue increased 8% year-over-year Added $13 million in Net New Annual Recurring Revenue in Q4 Net Dollar Retention Rate stabilized at 97% for Large Customers and 93% total Expanded full year 2025 Adjusted EBITDA Margin by 700 basis points Udemy (NASDAQ:UDMY), a leading AI-powered skills acceleration platform, today reported results for the three- and twelve-month periods ended December 31, 2025. In light of the pending combination with Coursera (NYSE:COUR), which remains subject to shareholder and regulatory approvals and other customary closing conditions, Udemy will not host a conference call to discuss the results and will not provide

    2/5/26 4:05:00 PM ET
    $COUR
    $UDMY
    Computer Software: Prepackaged Software
    Technology
    Other Consumer Services
    Real Estate

    U.S. Army Continues Investment in Oshkosh FMTV A2 LVADs with Additional $25 Million Order

    Oshkosh Defense, an Oshkosh Corporation (NYSE:OSK) company, announced today it was awarded an additional $25 million contract from the U.S. Army to deliver FMTV A2 Low-Velocity Airdrop (LVAD) 4x4 Cargo vehicles and kits. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260205936929/en/Oshkosh Defense FMTV A2 LVAD 4x4 and 6x6. This order, following a recent Army contract for 97 vehicles, demonstrates strong and sustained customer demand for mission-critical tactical mobility solutions in extreme environments. "This award underscores our commitment to supporting the U.S. Army with proven, mission-ready capabilities that perform wh

    2/5/26 8:45:00 AM ET
    $OSK
    Auto Manufacturing
    Industrials